Patient Case Study: Polycystic Liver and Kidney Disease + Gastric Mass

Patient Case Study: Polycystic Liver and Kidney Disease + Gastric Mass

We’re highlighting compelling patient stories that reveal the value of proactive healthcare and whole-body MRI (WB-MRI). These cases demonstrate how advanced imaging can uncover significant health insights, even in asymptomatic individuals, allowing for timely intervention and better outcomes.

Our latest case features a 68-year-old female whose screening WB-MRI uncovered polycystic liver disease—a variant of autosomal dominant polycystic kidney disease (ADPKD)—and a small gastric mass suggestive of a gastrointestinal stromal tumor (GIST).

Here’s the full story...

Patient History

  • A 68-year-old female underwent screening WB-MRI without reporting specific concerns or relevant medical history.

Findings

  • Polycystic Liver and Kidney Disease: Polycystic liver disease (PLD) was noted, with more extensive involvement than the kidneys, suspicious for a liver predominant variant of hereditary autosomal dominant polycystic kidney disease (ADPKD).
  • Small Gastric Mass: A small mass centered within the gastric wall was detected, with imaging features favoring a gastrointestinal stromal tumor (GIST).

How the Prenuvo Scan Impacted Patient Care

This WB-MRI highlights the value of screening in uncovering asymptomatic, clinically significant conditions spanning multiple organ systems:

  • Polycystic Liver and Kidney Disease (PLD and PKD): The prevalence of ADPKD is estimated at 1 in 1,000 individuals. Early detection allows for preventive care, including specialist referrals to monitor organ function, manage complications, and adopt lifestyle changes to preserve health. Genetic-testing and counseling could be of value for potentially affected family members if hereditary ADPKD is confirmed.
  • Small Gastric Mass compatible with GIST: GISTs are rare mesenchymal tumors of the gastrointestinal tract, with an annual incidence of about 10-15 per million population, commonly occurring in the stomach (60-70% of cases). Early detection of GISTs is crucial, as size and rate of cell division are key prognostic factors.
  • The likely GIST was identified before symptoms or progression, enabling timely endoscopic evaluation, biopsy, and potential treatment or active monitoring to enable patient-specific optimal outcomes.

Key Benefits of WB-MRI in This Case

  1. Multi-System Detection: Simultaneous identification of liver, kidney, and gastrointestinal conditions underscores WB-MRI’s comprehensive screening capabilities.
  2. Proactive Care and Minimizing Morbidity: Early findings enable preventive care to reduce complications like renal failure or malignant transformation.

This case underscores how WB-MRI can serve as a powerful diagnostic tool, identifying both systemic and focal pathologies, enabling proactive, life-preserving care for asymptomatic individuals.

?Left image: Axial T2-weighted image centered at the abdomen at the level of the liver, which demonstrates multiple cysts in the liver. Right image: Slightly lower down in the abdomen, another slice centered at the level of the kidneys shows multiple cysts in the left kidney.
?Left image: Additional axial T2-weighted image at the abdomen, now highlighting a small mass within the wall the stomach (red circle). Right image: The lesion can be seen to be diffusion-restriction on the corresponding DWIBS image (diffusion-weighted imaging with background suppression) compatible with hypercellular solid neoplasm (red circle on right image)

We’re continually inspired by the incredible impact proactive imaging has on patient care. Stay tuned for more real-life cases highlighting how WB-MRI transforms healthcare.


References:

Norcia LF, Watanabe EM, Hamamoto Filho PT, et al. Polycystic liver disease: pathophysiology, diagnosis and treatment. Hepat Med. 2022;14:135-161. doi:10.2147/HMER.S377530.

Khan J, Ullah A, Waheed A, et al. Gastrointestinal stromal tumors (GIST): a population-based study using the SEER database, including management and recent advances in targeted therapy. Cancers (Basel). 2022;14(15):3689. doi: 10.3390/cancers14153689.

要查看或添加评论,请登录

Prenuvo的更多文章

社区洞察

其他会员也浏览了